Company:  MOMENTA PHARMACEUTICALS I ... (MNTA)
Form Type:  8-K
Filing Date:  2/22/2013 
CIK:  0001235010 
Address:  675 WEST KENDALL STREET 
City, State, Zip:  CAMBRIDGE, Massachusetts 02142 
Telephone:  617 491-9700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$11.34  
Change: 
-0.15 (-1.31%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$629.25M
Description of Business
We are a biotechnology company operating in three product areas: Complex Generics, Biosimilars and Novel Drugs. Our approach is built around a complex systems analysis platform that we use to obtain a detailed understanding of complex chemical and biologic systems, design product candidates based on this knowledge, analyze sets of biological data to evaluate the biological function of our products, and develop manufacturing processes that enable our products to be reliably produced. Our first product, developed in collaboration with Sandoz, Enoxaparin Sodium Injection, a generic version of Lovenox�, was approved in July of 2010, validating the commercial value of our platform. In the period from commercial launch through September 2011, we capitalized on the advantage of having the only generic version of Lovenox in the marketplace and recognized over $340 million in revenue from this product.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02 Departure of Directors or Certain ...
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURE
BROKERAGE PARTNERS